Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decline of 45.1% from the March 15th total of 263,500 shares. Based on an average daily volume of 760,200 shares, the short-interest ratio is […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 263,500 shares, an increase of 449.0% from the February 28th total of 48,000 shares. Based on an average daily trading volume, of 2,740,000 shares, […]
With AirwayRx, clinicians can deliver aesthetic finishes to their obstructive sleep apnea patients without having to work against the treatment philosophy of their clear aligner company, according to Candid.
Vivos Therapeutics (NASDAQ:VVOS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Friday, Zacks.com reports. According to Zacks, “Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totalling 410,700 shares, an increase of 50.5% from the April 30th total of 272,800 shares. Currently, 2.4% of the shares of the stock are sold short. Based on […]